Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 37,353 $ 29,018
General and administrative 6,943 8,118
Total operating expenses 44,296 37,136
Loss from operations (44,296) (37,136)
Other income (expense):    
Interest income 1,076 1,487
Interest expense (636) (294)
Other income, net 341 0
Net loss (43,515) (35,943)
Other comprehensive income:    
Net unrealized loss on available-for-sale investments, net of tax (25) 0
Net comprehensive loss $ (43,540) $ (35,943)
Net loss per share, basic $ (0.39) $ (0.71)
Net loss per share, diluted $ (0.39) $ (0.71)
Weighted Average Number of Shares Outstanding, Basic 112,025,474 50,743,101
Weighted-average common shares outstanding diluted 112,025,474 50,743,101